Rejuvenate Bio

Biotechnology ResearchUnited States11-50 Employees

Rejuvenate Bio is a United States-based biotechnology research company with 11-50 employees and a public website at https://rejuvenatebio.com. It aims to address chronic age-related diseases by leveraging gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans. The company was founded on scientific research developed at the Wyss Institute at Harvard Medical School. In June 2026, Rejuvenate Bio announced a research and development collaboration with Merck Animal Health USA to advance therapies, reflecting its work in both human and animal health. Earlier, it announced a partnership to develop and commercialize a novel gene therapy for canine osteoarthritis.

Sign up for free to view info

Email Format Employee directory